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Abstract
Mitragyna speciosa is a species of tropical indigenous plant that can 
be found mainly in Southeast Asia. This study aims to ascertain the 
existence of antipyretic properties of the crude methanolic extract of 
Mitragynaspeciosa, and determine its effective dose against Brewer’s 
yeast-induced pyrexia in mice. Thirty BALB/c mice were randomly 
divided into three treatment groups and two control groups. Pyrexia 
was induced by subcutaneous injection of 30% Brewer’s yeast. Rectal 
temperature was recorded before and 18 h after induction of pyrexia every 
30 min for 5 h. All groups treated with the crude methanolic extracts of 
Mitragynaspeciosa (50 mg/kg, 100 mg/kg, 200 mg/kg) were observed 
to produce significantreduction of rectal temperature as compared to 
the negative control group at different times. Ketoprofen at the dosage 
of 1 mg/kg caused significant (p<0.001) inhibition of fever from 0.5 
to 5.0 h after treatment. In conclusion, the crude methanolic extract of 
Mitragyna speciosa possessed dose-dependent antipyretic properties in 
mice. The antipyretic effective dose of the crude methanolic extract of 
Mitragyna speciosa was 100 mg/kg.
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Introduction
Mitragyna speciosa (commonly known as “kratom”, “ketom”, “ketum”, or “biak-
biak”) is a tree which is part of the family Rubiaceae. Genus mitragyna can usually 
be found in swamp and valleys in tropical and subtropical Asia such as Thailand, 
Laos, Cambodia, Malaysia (Burkill, 1935) and in the East and West Africa and 
India (Harvala and Hinou, 1988).  In Malaysia, this species can be widely found 
in the northern half of the Peninsula (Burkill, 1935) and Selangor (Houghton and 
Said, 1986). 
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 Effects of Mitragyna speciosa are known to be dose-dependent, where at high 
doses the subjects usually exhibited opioid-like effects, while at lower doses, it 
tends to result in stimulant-like effects. Its usage to treat pain and opium withdrawal 
syndrome was described as early as the nineteenth century (Shellard, 1989). 
 However, there is no scientific data on the antipyretic effect of the crude extract 
of Mitragyna speciosa. Therefore, the objectives of this study were to determine 
the antipyretic effect of crude methanolic extract of Mitragyna speciosa in mice 
and the effective dose of crude methanolic extract of Mitragyna speciosa against 
Brewer’s yeast-induced pyrexia in mice. 
Materials and Methods
Preparation of the crude methanolic extract of Mitragyna speciosa 
and ketoprofen
Ketoprofen 20 mg tablet was crushed using mortar and pastel. The ketoprofen 
powder or the crude methanolic extract of Mitragyna speciosa was then dissolved 
in 20% Tween 80 using a magnetic stirrer until a homogenous solution was 
achieved. This homogenous solution was then mixed with 0.9% NaCl, and stirred 
using a magnetic stirrer until a homogenous, foamy solution was produced. 
Animals
Thirty BALB/c female mice weighing 20 to 25 g were used. The mice were 
acclimatized for at least one week and housed eight per cage under standard 12-h 
light: 12-h dark cycle. Food and water were available ad libitum. Mice were allowed 
to acclimatize to the laboratory environment 24 h prior to experimentation.
Antipyretic activity
The antipyretic activity was evaluated in mice according to the method described by 
Makonnen et al. (2003).  A thermister probe was inserted about 1 cm into the rectum 
of the mice, and basal rectal temperature was recorded by a digital thermometer. 
Pyrexia was induced by injection of 30% (w/v) suspension of Brewer’s yeast in 
0.9% NaCl subcutaneously at the dosage of 10 mL/kg. The rectal temperature was 
recorded 18 h after the induction of pyrexia. Only mice which showed increase in 
the rectal temperature of > 0.5°C were subjected to the experiments.
Dosage test 
The crude methanolic extract of Mitragyna speciosa, ketoprofen (positive 
control), and 20% Tween 80 in 0.9% NaCl (negative control) were administered 
intraperitoneally. For each dosing, six mice were used. The crude methanolic 
extract of Mitragyna speciosa was administered at the dosage of 50 mg/kg, 100 
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mg/kg, and 200 mg/kg. Ketoprofen was administered at the dosage of 1 mg/kg. 
As for the negative control group, the vehicle (20% Tween 80 in 0.9% NaCl) was 
administered at the dosage of 10 mL/kg. Eighteen hours after the induction of 
pyrexia, and immediately after dosing crude extract, the rectal temperature was 
measured every 30 min for 5 h.
Analysis of data
The mean change in the rectal temperature over the 5 h period was calculated 
for each mouse and expressed as percentage of reduction. All the data from the 
experiments were analysed using SPSS version 16.0. The data were analyzed using 
General Linear Model repeated measure ANOVA. The results were expressed as 
mean ± S.E.M. and the statistical significance (P<0.05, P<0.01, P<0.001) between 
the treatment group to the negative control group were analyzed using one-way 
ANOVA followed by Tukey’s test at each point of time.
Results and Discussion
In the negative control group, the subcutaneous injection of 30% Brewer’s yeast 
has increased the body temperature to 38°C which was maintained for 5 h, and the 
highest temperature was recorded at 1.0 h (38.67°C). All treated groups showed 
significantly lower rectal temperature as compared to the negative control group.
From Figure 1, ketoprofen (1 mg/kg)-treated group showed significant reduction 
in rectal temperature from 0.5 to 1.0 h, and from 3.5 to 5.0 h. Ketoprofen was 
observed to produce the highest percentage of inhibition of fever at 5.0 h (36.65°C).
 As shown in Table 1, mice treated with the methanolic extract of Mitragyna 
speciosaat the dose of 50 mg/kg had significant (P<0.05) reduction in rectal 
temperature from 2.5 h until 5.0 h. At the dosage of 100 mg/kg, Mitragyna speciosa 
seems to produce significant (P<0.05) reduction in temperature at 0.5 h and, from
2.0 to 5.0 h. The group of mice treated with the crude methanolic extract of 
Mitragyna speciosa at the dosage of 200 mg/kg resulted in significant reduction 
(P<0.001) in rectal temperature from 0.5 to 5.0 h. The greatest percentage of 
reduction of temperature can be seen in the group treated at the dosage of 200 
mg/kg, at 2.0 h. However, administration of methanolic extracts of Mitragyna 
speciosaat a dose of 200 mg/kg caused hypothermia in mice from 1.0 to 3.5 h.
 The dose-dependent effect of the methanolic extract of Mitragyna speciosa 
also revealed findings similar to that reported by Babu et al. (2008), where opiate 
or morphine-like effects seem to predominate when high dose of Mitragyna 
speciosa extract were administered. In this study, administration of 200 mg/kg 
of the crude methanolic extract induced hypothermia in mice for 2.5 h. This is 
possibly due to the presence of other compounds in the crude extract, which may 
act synergistically to produce more potent hypothermic effect than that of a single 
compound.
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 Thus, it was shown that the effective antipyretic dose for the crude methanolic 
extract of Mitragyna speciosa was 100 mg/kg. The results also showed that 
ketoprofen, known to inhibit the cyclo-oxygenase, causes significant inhibition of 
pyrexia. It is assumed that the mode of action of antipyretic activities of Mitragyna 
speciosa methanolic extract might involve a mechanism possibly mediated via 
inhibition of cyclo-oxygenase activity. However, more studies need to be carried 
out to determine the actual mechanism of action of the antipyretic properties of 
Mitragyna speciosa.
Conclusion
This study revealed that the crude methanolic extract of Mitragyna speciosa 
possesses a dose-dependent antipyretic effect, where the highest dose of the crude 
extract resulted in opioid-like effect.The antipyretic effective dose of the crude 
methanolic extract of Mitragyna speciosa was 100 mg/kg.
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Figure 1. Percentage reduction of fever in Brewer’s yeast-induced pyrexia in mice treated 
with the crude methanolic extract of Mitragyna speciosa. n= 6, data= mean ± 
S.E.M., all values marked with asterisk are statistically significant * P<0.05, ** 
P<0.01, *** P<0.001 compared to negative control.
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